Apoptosis in multiple sclerosis - etiopathogenetic relevance and perspectives for new therapeutic strategies

被引:0
|
作者
Aktas, O [1 ]
Wendling, U [1 ]
Zschenderlein, R [1 ]
Zipp, F [1 ]
机构
[1] Humboldt Univ, Fak Med, Neurol Klin & Poliklin, D-1040 Berlin, Germany
来源
NERVENARZT | 2000年 / 71卷 / 10期
关键词
multiple sclerosis; apoptosis; immunopathogenesis; CD95; TNF;
D O I
10.1007/s001150050664
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Apoptosis, or programmed cell death, is a physiological cell suicide program mainly leading to selective elimination of useless cells. This mechanism is important for the homeostasis of the immune system and presumably plays a two-sided role in the pathogenesis of multiple sclerosis (MS). On the one hand, evidence has been provided that impaired apoptosis might result in increased numbers or persistence of activated myelin-specifier cells, thus inducing the pathophysiologic processes in MS. On the other hand, local tissue damage might involve apoptosis of glial and neuronal cells and lead to the clinical symptoms. Here, an overview is presented on the current knowledge of the role of apoptosis in the pathogenesis of MS, and implications for related therapeutic strategies are discussed.
引用
收藏
页码:767 / 773
页数:9
相关论文
共 50 条
  • [21] Immune mechanisms of new therapeutic strategies in multiple sclerosis-A focus on alemtuzumab
    Klotz, Luisa
    Meuth, Sven G.
    Wiendl, Heinz
    CLINICAL IMMUNOLOGY, 2012, 142 (01) : 25 - 30
  • [22] Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis
    Tan, Yossan-Var
    Waschek, James A.
    ASN NEURO, 2011, 3 (04): : 195 - 212
  • [23] Towards a comprehensive etiopathogenetic and pathophysiological theory of multiple sclerosis
    Tobore, Tobore Onojighofia
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2020, 130 (03) : 279 - 300
  • [24] New perspectives on living with Multiple Sclerosis
    Healy, C
    AUSTRALIAN JOURNAL OF PSYCHOLOGY, 2003, 55 : 6 - 6
  • [25] NEW PERSPECTIVES IN MULTIPLE-SCLEROSIS
    PATY, DW
    CANADIAN FAMILY PHYSICIAN, 1989, 35 : 2123 - 2125
  • [26] Cannabinoid system and neuroinflammation:: Therapeutic perspectives in multiple sclerosis
    Mestre, L.
    Correa, F.
    Docagne, F.
    Clemente, D.
    Ortega-Gutierrez, S.
    Arevalo-Martin, A.
    Molina-Holgado, E.
    Borrell, J.
    Guaza, C.
    REVISTA DE NEUROLOGIA, 2006, 43 (09) : 541 - 548
  • [27] New Therapeutic Options in Multiple Sclerosis
    Salmen, A.
    Chan, A.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2015, 83 (03) : 174 - 184
  • [28] New therapeutic approaches for multiple sclerosis
    De Jager, Philip L.
    Hafler, David A.
    ANNUAL REVIEW OF MEDICINE, 2007, 58 : 417 - 432
  • [29] New therapeutic approaches in multiple sclerosis
    Rieckmann, P
    Kallmann, B
    NERVENHEILKUNDE, 2005, 24 (04) : 294 - 300
  • [30] Repair strategies for multiple sclerosis: challenges, achievements and perspectives
    Stankoff, Bruno
    Jadasz, Janusz Joachim
    Hartung, Hans-Peter
    Kury, Patrick
    Zalc, Bernard
    Lubetzki, Catherine
    CURRENT OPINION IN NEUROLOGY, 2016, 29 (03) : 286 - 292